Tokyo, Japan

Shinji Tsutsumi

This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Tsutsumi. Retrieved from https://idiyas.com/inventor/shinji-tsutsumi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shinji Tsutsumi

Introduction

Shinji Tsutsumi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work focuses on creating innovative solutions that address specific biological activities.

Latest Patents

One of Tsutsumi's key patents is a 3-phenylpropylamine derivative. This invention aims to provide a novel compound with SF-1 antagonist activity. The patent describes a polyfunctional molecule that includes a moiety corresponding to the compound, specifically an SF-1 degrader. The compound is represented by a specific formula, showcasing Tsutsumi's expertise in chemical innovation.

Career Highlights

Shinji Tsutsumi is associated with Daiichi Sankyo Company, Limited, a leading pharmaceutical company. His role at the company allows him to engage in cutting-edge research and development. Tsutsumi's work has contributed to advancements in therapeutic options for various medical conditions.

Collaborations

Throughout his career, Tsutsumi has collaborated with talented individuals such as Hideaki Kageji and Tomoharu Tsukada. These collaborations have fostered a creative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Shinji Tsutsumi's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for new therapeutic advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…